This brand name is authorized in Estonia, Netherlands
The drug SELENASE contains one active pharmaceutical ingredient (API):
|
1
Sodium selenite
UNII HIW548RQ3W - SODIUM SELENITE
|
|
Selenium is an essential trace element. In human, selenium compounds are glutathione peroxidase and a selenium protein P found in the plasma. Deficiency of selenium has been associated with an endemic form of cardiomyopathy, Keshan disease and with Kaschin-Beck disease, an endemic osteoarthropathy which causes a severe deformity of the joints. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A12CE02 | Sodium selenite | A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CE Selenium |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1877654 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14812525, 14812533, 14812991, 14814250 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 67687, 67695, 67709, 67717 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
